Clinical Trial Update: A Double-blind, Group-comparison Study Using Zolpidem (Myslee) as a Comparative Drug in Patients With Insomnia [Phase 3]

View source ↗

Summary

Phase 3 double-blind, group-comparison trial uses Zolpidem (Myslee) as the comparator in patients with insomnia; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Drugs mentioned

• Myslee (zolpidem)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Sleep Initiation and Maintenance Disorders, Sleep Disorders | Phase 3 | Status: COMPLETED